The role of laboratory tests as a prognostic marker for immune-checkpoint therapy in non-small cell lung cancer

Transl Lung Cancer Res. 2023 Sep 28;12(9):1838-1841. doi: 10.21037/tlcr-23-566. Epub 2023 Sep 14.
No abstract available

Keywords: C-reactive protein (CRP); Immune-checkpoint therapy; lactate dehydrogenase (LDH); neutrophil-lymphocyte ratio (NLR); non-small cell lung cancer (NSCLC).

Publication types

  • Editorial
  • Comment